International Society on Thrombosis and Haemostasis (ISTH)
An l R t
2024
TABLE OF CONTENTS
Introduction
ISTH overview and strategic plan
President’s message
Membership overview
Awards and recognition
Meetings update
Educational programs
Guidelines and guidance committee
Scientific and standardization committee (SSC)
Publications
External relations and World Thrombosis Day
Industry relations and philanthropy
Financial summary
Our appreciation
WE ARE THE ISTH
The International Society on Thrombosis and Haemostasis (ISTH) is a global organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. With a mission to promote education, research and collaboration in the field, the ISTH strives to improve patient care and outcomes worldwide. Through interdisciplinary cooperation and innovative approaches, the ISTH drives progress in thrombosis and hemostasis science, enhancing public health and well-being.
ctives, experiences and cultural contexts. By fostering an s inclusive leadership, the Society advances excellence in driven by communities that are open, reflective and united reflects these values.
ISTH STRATEGIC PLANNING
The ISTH 2024-2028 Strategic Plan defines the following four priority goals that the Society has committed itself to focus on over the next five years:
Foster connection and collaboration within the field of thrombosis and hemostasis and across different fields of science and medicine, as well as involve, recognize and support early career professionals. This includes interdisciplinary interactions within the fields of hematology, cardiology, neurology, critical care medicine, molecular and cellular medicine, computer sciences and others. Broaden and intensify the reach and collaborations through a more intentional engagement with organizations in countries around the world and be even more welcoming to a wider and more diverse group of professionals, particularly from under-represented demographics. Increase access to targeted areas of research funding within and outside of the ISTH.
Increase speed, quality, access and applicability of resources on new developments and technologies.
DIVERSITY, EQUITY AND INCLUSION
The ISTH fosters a culture that celebrates the unique identities and recognizes the contributions of each member. We strive to harness the potential of our diverse community to deliver transformative research and clinical practices for the benefit of all people.
Every action of the ISTH is grounded in these guiding principles, and the ISTH commits to actions that advance the following tenets:
With science, technology and medicine rapidly evolving, the ISTH aims to expand its fields of research and impact becoming even more inclusive and impactful. This will allow us to champion major scientific discoveries in our field, as well as shape clinical and laboratory practice.
Cultivate diverse leadership and visible representatives within all levels of the Society. Create an inclusive environment that allows every member to fully participate and contribute in scientific discourse and Societal decisions. Empower our members to champion diversity, equity and inclusion, and to hold each other accountable to these commitments.
ISTH PRESIDENT PANTEP ANGCHAISUKSIRI, M.D. BUILDING ON OUR SUCCESSFUL LEGACY
Pantep Angchaisuksiri, M.D. ISTH President (Th
il d)
I am filled with gratitude and pride for the incredible strides we made together in 2024 at the ISTH. My term as ISTH President began with great excitement and a deep sense of responsibility, and it has been a true honor to serve in this role.
The highlight of the year for me, both professionally and personally, was welcoming many of you to my home city of Bangkok, Thailand, for the ISTH 2024 Congress. The Congress was a tremendous success not only in terms of attendance and scientific exchange, but also in the meaningful connections forged among colleagues from around the world.
Throughout 2024, the Society made important progress on its strategic plan, which continues to serve as our roadmap for advancing science, education and clinical care in thrombosis and hemostasis. We are focused on expanding global access to resources, supporting career development at every level and creating more opportunities for collaboration across disciplines and regions.
I’m particularly proud of our efforts to engage more early career professionals and to ensure that the ISTH remains a vibrant, inclusive and innovative organization. We’ve also seen growth across all areas of the Society from the launch of new educational initiatives and guidelines to the increasing global reach of World Thrombosis Day.
The ISTH continues to lead with integrity and purpose, and that is a testament to the dedication to our members like you. Your contributions are what drive our mission forward, and I thank each of you for the time, expertise, and passion you bring to this community.
As we look ahead to 2025, I invite you to join us in Washington, D.C., for the next ISTH Congress. It promises to be another exciting opportunity to share groundbreaking science and strengthen our global network. Until then, thank you for making 2024 such a remarkable year. It is a privilege to serve as your President, and I look forward to what we will accomplish together in the year ahead.
ISTH: WHERE YOUR IMPACT BEGINS MEMBERS
BY AGE
Free Academy members
Countries
Increase in Reach-the-World memberships
Participants in Mentor-Mentee Match program
*Other includes the following categories: Non-conforming, selected more than one option, non-binary and/or different gender identity.
INSPIRING THE NEXT GENERATION OF LEADERS
MEMBERS BY GEOGRAPHIC REGION
MEMBERSHIP PROGRAMS: SKILLS DIRECTORY
COLLABORATION NETWORK
MY ISTH COMMUNITY
MENTOR-MENTEE MATCH
AWARDS AND RECOGNITION
ROBERT P. GRANT MEDAL
Andreas Greinacher, M.D.
University of Greifswald (Germany)
HAROLD R. ROBERTS AWARD
David Lillicrap, M.D.
Queen’s University (Canada)
OUTSTANDING MENTOR AWARD
Alisa Wolberg, Ph.D.
University of North Carolina at Chapel Hill (U.S.)
OUTSTANDING MENTOR AWARD
Marc Carrier, M.D.
The Ottawa Hospital (Canada)
ISTH 2024 CONGRESS HIGHLIGHTS
The ISTH Congress is the premier global event in thrombosis and hemostasis, bringing together thousands of the world’s leading experts to exchange groundbreaking science, foster collaboration and shape the future of the field.
4,354 TOTAL REGISTRATIONS
3,858 IN-PERSON
496 VIRTUAL
1,929 ABSTRACTS RECEIVED
Guy Young, M.D. Vice Chair (U.S.)
Christopher Ward, M.D., Ph.D. Chair (Australia)
IS ACTION
The ISTH Academy is the Society’s online education platform, offering hundreds of webinars, courses and recorded webcasts. It’s the go-to resource for staying current, advancing your expertise and connecting with leading voices in thrombosis and hemostasis.
13 NEW WEBINARS
144 AVERAGE LIVE VIEWS PER WEBINAR
50 PARTICIPANTS IN TEAM-BASED LEARNING COURSE (STUDENTS AND FACILITATORS)
GLOBAL LEARNING THAT LEADS
The ISTH education program offers world-class, accessible learning designed to advance knowledge and clinical practice in thrombosis and hemostasis. Through expert-led courses, interactive resources and innovative tools, it empowers professionals at every stage of their careers to stay at the forefront of the field.
THE #s
5 Reach-the-World Fellowships and 5 Regional Training Center travel awards
7 Training Fellowships awarded
3 Fundamental Research Workshops held in Spain, Australia and the United States
3 Fundamental Research Career Development Awards
2 Reach-the-World Education Courses held in Argentina and Cambodia 4 Regional Training Center partnerships
“Brilliant workshop which had just the right number of people attending...I found the highlights sessions really useful.”
GUIDELINES AND GUIDANCE
The ISTH Guidelines and Guidance Committee develops, oversees and coordinates the development and/or approval of thrombosis and hemostasis guidelines. As part of its mission, the ISTH develops and disseminates evidence-based clinical practice guidelines and guidance for the diagnosis and management of a wide range of conditions associated with thrombosis and hemostasis, with the goal of enhancing the health and quality of life of individuals globally.
ASH-ISTH Pediatric VTE Prophylaxis Guideline launched
Inaugural Guidelines and Guidance Session at Annual Congress
ISTH Treatment of Congenital Hemophilia A and B Guideline published
ASH-ISTH Pediatric VTE Treatment Guideline submitted for publication
Launched second “From Guidance to Practice” recording
Kathleen Freson, Ph.D.
SSC Chair (Belgium)
Jerrold Levy, M.D.
The ISTH Scientific and Standardization Committee (SSC) is a permanent committee of the ISTH and is its scientific working arm. Its activities promote cooperation among leading international scientists and direct their energies to projects that generate reliable and standardized clinical and basic science tools.
BY THE #s
Countries represented on the SSC Board
Subcommittees + standing committees + working group
SSC Vice Chair (U.S.)
Activities registries ran by the SSC
Official communications issued by the SSC
SSC grants awarded SSC on the Case webinars
Joost Meijers, Ph.D.
Immediate Past SSC Chair (The Netherlands)
EXTERNAL RELATIONS
GLOBAL PUBLIC AFFAIRS
Engaged the WHO Executive Board:
Represented the ISTH at the February 2024 World Health Organization (WHO) Executive Board Meeting and co-signed key joint statements advancing thrombosis and hemostasis priorities on the global health agenda.
Established EMA relations:
Achieved official relations status with the European Medicines Agency (EMA), enhancing the ISTH’s role in regulatory policy and scientific collaboration.
Launched Global Public Affairs Committee:
Formal committee established and co-led by Flora Peyvandi, M.D., Ph.D., and Donna DiMichele, M.D., to drive coordinated international advocacy.
Expanded advocacy alliances:
Strengthened ETHA’s engagement through collaboration with EACH at two key events, shared funding opportunities and monthly communication with its 28 member societies. Continued collaboration with the Global Coalition for Circulatory Health.
Increased engagements and partnerships:
WORLD THROMBOSIS DAY
World Thrombosis Day is a global awareness campaign dedicated to reducing death and disability caused by thrombosis, including conditions like deep vein thrombosis and pulmonary embolism. It is led by the ISTH and supported by a global network of 8,000+ partners and advocates across 123 countries.
4.4 billion
3.3 billion Media impressions 7.2 million Ad spend impressions
400%
Increase in website sessions
14 New language translations 33% Social media engagement rate increase
WORLD-CLASS PUBLICATIONS
Michael Makris, M.D.
RPTH Editor-in-Chief (United Kingdom)
Suzanne Cannegieter M.D., Ph.D., M.S.c
JTH Editor-in-Chief (The
Ton Lisman, Ph.D.
JTH Editor-in-Chief (The Netherlands)
ISTH INDUSTRY RELATIONS AND
PHILANTHROPY
CORPORATE SUPPORT BY THE #s
8 SUPPORTERS FOR WORLD THROMBOSIS DAY
16 SUPPORTERS FOR EDUCATION PROGRAMS
12 INDUSTRY ROUNDTABLE MEMBERS
The ISTH Industry Roundtable provides a forum for discussions between industry partners and ISTH leaders, including scientific advancements, education, the future of diagnosis and care, and the needs of the global scientific and clinical community.
The ISTH benefited from the generosity of many individual donors who contributed to support the many important activities of the Society, including the Claire McLintock Memorial Award. A fellowship on women’s health, supported by these funds, will be announced and awarded in 2025.
Thank you to our generous donors
2024 top donors:
Jerrold H. Levy
Amber Payne in memory of the Nick Payne Memorial 5K
Madhu Bajaj in memory of Paul Bajaj
James Douketis
Click to donate and see a list of donors.
INTERESTED IN SUPPORTING THE ISTH MISSION AND PROGRAMS? CONTACT ISTH’S EXECUTIVE DIRECTOR AT TOM REISER@ISTH.ORG FOR MORE INFORMATION.
2024 REVENUE: $10,188,748
FUNDRAISING GENERAL BUSINESS ADMINISTRATION
PUBLICATIONS
MEETINGS/CONGRESS
FUNDRAISING
2024 EXPENSES: $13,221,124
GENERAL BUSINESS ADMINISTRATION
MEETINGS/CONGRESS
FINANCIAL UPDATE
The ISTH remains in a financially healthy position, with reserves exceeding one year of full operating expenses—underscoring our continued fiscal stability. Despite an intentionally planned operating loss in support of the Society’s global mission in 2024, we maintained support for our core programs and strategic initiatives, reinforcing our commitment to advancing the field of thrombosis and hemostasis.
OUR APPRECIATION
The ISTH extends its gratitude to the entire ISTH community for your time, passion and tireless efforts to move our mission forward. Your contributions make everything we do possible. The ISTH would also like to express its appreciation to all members of the ISTH Council, as well as chairs and members of the 15 ISTH committees for their leadership and dedication.
The ISTH also shares special appreciation to all to the chairs, co-chairs and members of the ISTH’s Scientific and Standardization Committee (SSC) committees, subcommittees and working groups members. Thank you for your commitment to advancing the Society’s research, standardization, nomenclature and guidance programs conducted by the SSC.
Together, we look forward to working together to continue the ISTH mission. Your generosity, collaboration and spirit of service inspire us and empower the global ISTH community to thrive. Thank you to our tremendous volunteer leaders!
CONTACT INFORMATION
